• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Abbott, GE Healthcare ink afib deal

Abbott, GE Healthcare ink afib deal

May 13, 2015 By Brad Perriello

Abbott, GE Healthcare ink afib deal

Abbott (NYSE:ABT) and General Electric (NYSE:GE) today said they inked a deal to integrate a pair of technologies designed to detect and map atrial fibrillation.

The deal calls for Abbott to integrate GE Healthcare’s CardioLab electrophysiology recording system into the RhythmView mapping software it acquired when it bought Topera Medical last year.

The companies claimed the combined technologies marks the 1st time physicians will be able to use instantaneous electrical heart data to diagnose atrial fibrillation sources.

"At Abbott, we are excited about collaborating with GE to help doctors more quickly diagnose the source of heart rhythm disorders with innovative technologies that combine the expertise and heritage of each company in improving patient care," electrophysiology vice president Mike Pederson said in prepared remarks.

David Tolan, electrophysiology global product manager for GE Healthcare, added that proper diagnosis of arrhythmias requires "intuitive, accurate, and reliable equipment."

"By leveraging the existing capabilities of GE’s CardioLab to extract and send saved data to the RhythmView System, doctors have a comprehensive tool to help give them the confidence to quickly diagnose the source of heart rhythm disorders, help improve outcomes and increase patient satisfaction," Tolan said.

Abbott paid $250 million up front and put another, unspecified amount on the table for Topera last December. Menlo Park, Calif.-based Topera won 510(k) clearance from the FDA in January 2014 for the latest incarnation of its 3D mapping system, including the RhythmView workstation and FIRMap diagnostic catheter. The imaging system uses electrical signals, captured by a multipolar electrophysiology catheter, to create 3D images mapping out cardiac arrhythmias.

Filed Under: News Well Tagged With: Abbott, GE Healthcare, Topera Medical

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy